ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-83

  1. 1,089 Posts.
    lightbulb Created with Sketch. 126
    75 million more shares at 0.5c
    We ain't going nowhere for a while...
    Oh joy!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.